Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Ekso Bionics Holdings Inc (NASDAQ: EKSO) closed the day trading at $3.59 down -7.95% from the previous closing price of $3.90. In other words, the price has decreased by -$7.95 from its previous closing price. On the day, 3.24 million shares were traded. EKSO stock price reached its highest trading level at $4.03 during the session, while it also had its lowest trading level at $3.5201.
Ratios:
For a better understanding of EKSO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.77 and its Current Ratio is at 2.35. In the meantime, Its Debt-to-Equity ratio is 0.44 whereas as Long-Term Debt/Eq ratio is at 0.31.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EKSO now has a Market Capitalization of 8496345 and an Enterprise Value of 4513954. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.49 while its Price-to-Book (P/B) ratio in mrq is 0.53. Its current Enterprise Value per Revenue stands at 0.257 whereas that against EBITDA is -0.508.
Stock Price History:
The Beta on a monthly basis for EKSO is 0.89, which has changed by -0.76763755 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, EKSO has reached a high of $22.95, while it has fallen to a 52-week low of $3.46. The 50-Day Moving Average of the stock is -34.09%, while the 200-Day Moving Average is calculated to be -63.37%.
Shares Statistics:
Over the past 3-months, EKSO traded about 147.05K shares per day on average, while over the past 10 days, EKSO traded about 361650 shares per day. A total of 2.40M shares are outstanding, with a floating share count of 2.11M. Insiders hold about 12.09% of the company’s shares, while institutions hold 10.64% stake in the company. Shares short for EKSO as of 1748563200 were 76753 with a Short Ratio of 0.52, compared to 1745971200 on 21747. Therefore, it implies a Short% of Shares Outstanding of 76753 and a Short% of Float of 3.3099998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
2 analysts predict $4.31M in revenue for the current quarter. It ranges from a high estimate of $4.62M to a low estimate of $4M. As of the current estimate, Ekso Bionics Holdings Inc’s year-ago sales were $4.95MFor the next quarter, 2 analysts are estimating revenue of $4.15M. There is a high estimate of $4.29M for the next quarter, whereas the lowest estimate is $4M.
A total of 2 analysts have provided revenue estimates for EKSO’s current fiscal year. The highest revenue estimate was $18.22M, while the lowest revenue estimate was $17M, resulting in an average revenue estimate of $17.61M. In the same quarter a year ago, actual revenue was $17.93MBased on 2 analysts’ estimates, the company’s revenue will be $25.06M in the next fiscal year. The high estimate is $26.9M and the low estimate is $23.21M.
